Compugen to Present New Clinical and Research Data in Two Oral Presentations at SITC 2022
/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today...
Source: prnewswire.com